𧬠Updates to the WHO Classification of Endocrine Tumors highlight how molecular markers such as BRAF-like and RAS-like mutations can refine thyroid cancer diagnosis and risk stratification, supporting more targeted treatment decisions. π― #ThyroidCancer
mdpi.com/2227-9059/12...
